search
Back to results

Participation and Detection Rate of Screening CT Colonography and Screening Sigmoidoscopy (Proteus)

Primary Purpose

Colorectal Cancer

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Invitation to screening
Sponsored by
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Colorectal Cancer focused on measuring CRC

Eligibility Criteria

58 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Asymptomatic individuals, at average risk for CRC, 58-60 years old.

Exclusion Criteria:

  • Personal history of CRC or polyps
  • Family history of CRC or polyps
  • A terminal illness or inflammatory bowel disease
  • Previous five years complete colonoscopy or a FOBT within the previous 2 years
  • Patients who are unable to give informed consent

Sites / Locations

  • S.C.D.O. Epidemiologia dei Tumori - Azienda Ospedaliera S. Giovanni Battista di Torino

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

CT Colonography (CTC)

Sigmoidoscopy (FS)

Arm Description

Invitation to screening. Subject who consent to participate in the study undergo to low dose CTC examination with limited bowel preparation.

Invitation to screening. Subjects who consent to participate in the study undergo to FS.

Outcomes

Primary Outcome Measures

Detection rate for cancer and advanced adenoma of CT Colonography versus FS in an invitational CRC screening program
Proportion of subjects detected with CRC or advanced adenomas out of those examined
Participation rate to FS and CT Colonography
Proportion of subjects attending the proposed examination out of those invited

Secondary Outcome Measures

Number of participants with severe adverse events in both screening groups
Absolute number of events
Costs of a CRC screening based on CTC
Unit cost of each procedures for participants
Type of false positive detections of Computer-aided detection for CTC in a CRC screening program
Characteristics of false positive subjects

Full Information

First Posted
May 23, 2012
Last Updated
January 29, 2020
Sponsor
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
Collaborators
im3D S.p.A., Regione Piemonte, Candiolo Cancer Institute - IRCCS
search

1. Study Identification

Unique Protocol Identification Number
NCT01739608
Brief Title
Participation and Detection Rate of Screening CT Colonography and Screening Sigmoidoscopy
Acronym
Proteus
Official Title
Assessment of the Participation Rate and the Diagnostic Accuracy of a Colorectal Cancer Screening Program: CT Colonography Versus Flexible Sigmoidoscopy. Evaluation of a New Model Based on Telediagnosis
Study Type
Interventional

2. Study Status

Record Verification Date
January 2020
Overall Recruitment Status
Completed
Study Start Date
December 2013 (Actual)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
December 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte
Collaborators
im3D S.p.A., Regione Piemonte, Candiolo Cancer Institute - IRCCS

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The objectives of this multicenter, randomized trial is to assess the participation rate achievable through two different screening strategies (Computed Tomographic Colonography-CTC and sigmoidoscopy-FS), to compare detection rate of colorectal cancer (CRC) and advanced adenoma of tests and to evaluate their costs. The role of Computer-aided detection (CAD) for CTC screening will be also assessed. The trial involves 10 Italian centers located in the Piedmont Region and in Verona. Residents aged 58-60 years in those districts are target for recruitment. Exclusion criteria include: previous diagnosis of cancer or adenoma; family history or hereditary syndromes; personal history of inflammatory bowel disease; patients screened by colonoscopy or FOBT within 2 years; severe disease.
Detailed Description
Design: To compare detection of advanced neoplasia of CT colonography (CTC) to sigmoidoscopy (FS), a total of 20.000 eligible individuals living in the target areas are mailed an invitation letter to participate in the trial. All invitees are asked to call the screening centre in order to receive detailed information about study protocol, the screening examinations and the bowel preparation. Responders who consent to participate in the study are randomly assigned to undergo screening with CTC or FS. All non-responders will be invited to Fecal Occult Blood test (FOBT) according to the current screening procedure. In the CTC arm, positive patients (containing at least one polyp 6 mm or larger) are referred to colonoscopy; negative patients (no polyps >5 mm) are scheduled to be invited to have an FOBT after two years. In the FS arm, positive patients (at least one advanced adenoma found during FS examination) are referred to colonoscopy; negative patients are offered no further follow-up. To compare participation rate to FS and CTC, 1200 individuals living in the target areas and never screened for colorectal cancer, are randomly assigned to receive an invitation for screening with CTC or FS. Individuals of both groups will receive an invitation letter and an information leaflet, containing information about colorectal cancer, importance of screening, and advantages and possible risks of the selected test. Invitation letter for CTC contains a phone number of the screening centre. All invitees are asked to call the screening centre in order to receive information about bowel preparation. All non-responders will receive a remainder by mail after one month. Non-responders to reminder will be invited to FS according with current screening procedure. In the CTC arm, positive patients (containing at least one polyp 6 mm or larger) are referred to colonoscopy; negative patients (no polyps >5 mm) are scheduled to be invited to have an FOBT after two years. In the FS arm, positive patients (at least one advanced adenoma found during FS examination) are referred to colonoscopy; negative patients are offered no further follow-up.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer
Keywords
CRC

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
40945 (Actual)

8. Arms, Groups, and Interventions

Arm Title
CT Colonography (CTC)
Arm Type
Experimental
Arm Description
Invitation to screening. Subject who consent to participate in the study undergo to low dose CTC examination with limited bowel preparation.
Arm Title
Sigmoidoscopy (FS)
Arm Type
Active Comparator
Arm Description
Invitation to screening. Subjects who consent to participate in the study undergo to FS.
Intervention Type
Other
Intervention Name(s)
Invitation to screening
Intervention Description
Invitation to screening
Primary Outcome Measure Information:
Title
Detection rate for cancer and advanced adenoma of CT Colonography versus FS in an invitational CRC screening program
Description
Proportion of subjects detected with CRC or advanced adenomas out of those examined
Time Frame
three years
Title
Participation rate to FS and CT Colonography
Description
Proportion of subjects attending the proposed examination out of those invited
Time Frame
one year
Secondary Outcome Measure Information:
Title
Number of participants with severe adverse events in both screening groups
Description
Absolute number of events
Time Frame
three years
Title
Costs of a CRC screening based on CTC
Description
Unit cost of each procedures for participants
Time Frame
three years
Title
Type of false positive detections of Computer-aided detection for CTC in a CRC screening program
Description
Characteristics of false positive subjects
Time Frame
three years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
58 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Asymptomatic individuals, at average risk for CRC, 58-60 years old. Exclusion Criteria: Personal history of CRC or polyps Family history of CRC or polyps A terminal illness or inflammatory bowel disease Previous five years complete colonoscopy or a FOBT within the previous 2 years Patients who are unable to give informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daniele Regge, MD
Organizational Affiliation
Institute for Cancer Research and Treatment at Candiolo
Official's Role
Principal Investigator
Facility Information:
Facility Name
S.C.D.O. Epidemiologia dei Tumori - Azienda Ospedaliera S. Giovanni Battista di Torino
City
Torino
State/Province
Piedmont
ZIP/Postal Code
10123
Country
Italy

12. IPD Sharing Statement

Citations:
PubMed Identifier
27196588
Citation
Regge D, Iussich G, Segnan N, Correale L, Hassan C, Arrigoni A, Asnaghi R, Bestagini P, Bulighin G, Cassinis MC, Ederle A, Ferraris A, Galatola G, Gallo T, Gandini G, Garretti L, Martina MC, Molinar D, Montemezzi S, Morra L, Motton M, Occhipinti P, Pinali L, Soardi GA, Senore C. Comparing CT colonography and flexible sigmoidoscopy: a randomised trial within a population-based screening programme. Gut. 2017 Aug;66(8):1434-1440. doi: 10.1136/gutjnl-2015-311278. Epub 2016 Apr 12.
Results Reference
derived
PubMed Identifier
24678896
Citation
Regge D, Iussich G, Senore C, Correale L, Hassan C, Bert A, Montemezzi S, Segnan N. Population screening for colorectal cancer by flexible sigmoidoscopy or CT colonography: study protocol for a multicenter randomized trial. Trials. 2014 Mar 28;15:97. doi: 10.1186/1745-6215-15-97.
Results Reference
derived

Learn more about this trial

Participation and Detection Rate of Screening CT Colonography and Screening Sigmoidoscopy

We'll reach out to this number within 24 hrs